SAN DIEGO (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, a biopharmaceutical company that develops targeted therapies for oncology and ophthalmology, today announced data being presented on TRC105 during two poster presentations at the 2013 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer… Read More
With the push for integrative health and collaborative care, now more than ever radiologists are serving in roles that transcend pure diagnostician. In an oncology specialty that espouses a multimodality, team-based approach, imaging is poised to fulfill, and go beyond,… Read More
Abstract Objective To evaluate the performance characteristics of florbetapir F18 positron emission tomography (PET) in patients with Alzheimer's disease (AD), mild cognitive impairment (MCI), and healthy control subjects (HCs). Methods Florbetapir PET was acquired in 184 subjects (45 AD patients,… Read More
SCOTTSDALE, Ariz. — Vismodegib, a new skin cancer drug for patients with advanced basal cell carcinoma tested by TGen, Virginia G. Piper Cancer Center at Scottsdale Healthcare and Mayo Clinic, is hailed as "the greatest advance in therapy yet seen"… Read More
Ron Korn, M.D. of Imaging Endpoints was recently asked about his team’s work toward the integration of imagery into drug discovery and development. While full integration is a thing of the future, the use of imagery in drug discovery and development can lend significant insights into the biology and efficacy of a drug.
Featured Webinar:
Radiologic Analysis of COVID-19 Infection
June 23, 2020
